TMPO-AS1 and hepatocellular carcinoma: Recent studies have demonstrated that TMPO antisense RNA 1 (TMPO-AS1) serves as a competing endogenous RNA to sponge microRNAs (miRNAs) in multiple carcinomas, including hepatocellular carcinoma, thyroid cancer, lung adenocarcinoma, and breast cancer (10–13).